Schedule 13G ownership disclosure

Corbus Pharmaceuticals Holdings, Inc.

Security class unavailable

Event date: 2018-10-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,167,349
Percent of class
7.2800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-18-011405
Form type
SC 13G
Filer
Corbus Pharmaceuticals Holdings, Inc.
CIK
CIK 1595097
Filed
Oct 29, 2018
Reporting period
Oct 23, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub